Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KEEL vs GSK✓SelectedUSD · GSKKEEL vs GSK performance historyLatest closeAs of-19.59%11/20
Stock and ETF performance explorer

KEEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.5%
GSK return
+53.4%
Excess return
-35.8%
Maximum drawdown
-81.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-19.6%-0.1%-19.5%-19.6%
7D-26.1%-5.3%-20.7%-27.3%
30D-42.7%-3.7%-39.1%-43.2%
3M-59.2%-7.3%-51.9%-59.8%
6M-67.5%-4.2%-63.3%-67.5%
YTD-41.5%+0.9%-42.4%-40.5%
1Y-47.1%+7.3%-54.4%-45.8%
3Y+17.5%+52.7%-35.2%+53.0%
All+17.5%+53.4%-35.8%+53.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling